{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:24:11Z","timestamp":1784204651886,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjms.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:08:24Z","timestamp":1753283304000},"page":"400-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rheumatologic manifestations in an X-Linked chronic granulomatous disease carrier"],"prefix":"10.1016","volume":"370","author":[{"given":"K. Quinn","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Oates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.amjms.2025.07.012_bib0001","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-7961-9-10","article-title":"Chronic granulomatous disease: a review of the infectious and inflammatory complications","volume":"9","author":"Song","year":"2011","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.amjms.2025.07.012_bib0003","series-title":"Chronic Granulomatous Disease and Other Disorders of Phagocyte Function: CGD Society Medical Guide","first-page":"4","year":"2019"},{"issue":"8","key":"10.1016\/j.amjms.2025.07.012_bib0004","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjms.2025.07.012_bib0005","series-title":"StatPearls [Internet]","article-title":"Chronic granulomatous disease. [Updated 2022 Dec 26]","author":"Lent-Schochet","year":"2024"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bmb\/ldw009","article-title":"Chronic granulomatous disease","volume":"118","author":"Roos","year":"2016","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","article-title":"Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases","volume":"138","author":"Conti","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2025.07.012_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"issue":"suppl_1","key":"10.1016\/j.amjms.2025.07.012_bib0009","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/jpids\/piy008","article-title":"Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease","volume":"7","author":"Rider","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.gendis.2019.07.010","article-title":"Recent advances in chronic granulomatous disease","volume":"7","author":"Anjani","year":"2019","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","article-title":"X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability","volume":"141","author":"Marciano","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2025.07.012_bib0012","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.012_bib0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2017.02.029","article-title":"Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom","volume":"140","author":"Battersby","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.012_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/eji.201040598","article-title":"CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species","volume":"41","author":"Pizzolla","year":"2011","journal-title":"Eur J Immunol"},{"issue":"7175","key":"10.1016\/j.amjms.2025.07.012_bib0016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.amjms.2025.07.012_bib0017","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2133.1981.tb08163.x","article-title":"Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease","volume":"104","author":"Brandrup","year":"1981","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.amjms.2025.07.012_bib0018","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s10875-022-01310-9","article-title":"Hematopoietic stem cell transplantation in late-onset X-linked chronic granulomatous disease in a female carrier [published correction appears in J Clin Immunol. 2022 Oct;42(7):1400. doi: 10.1007\/s10875-022-01334-1]","volume":"42","author":"Trevisan","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.amjms.2025.07.012_bib0019","article-title":"High symptom burden in female X-linked chronic granulomatous disease carriers","volume":"13","author":"Miranda","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.amjms.2025.07.012_bib0020","article-title":"Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease","volume":"25","author":"Patel","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.amjms.2025.07.012_bib0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bjh.16939","article-title":"Progress in treating chronic granulomatous disease","volume":"192","author":"Gennery","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjms.2025.07.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/252460","article-title":"Current concepts of hyperinflammation in chronic granulomatous disease","volume":"2012","author":"Rieber","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.012_bib0023","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","article-title":"Chronic granulomatous disease as a risk factor for autoimmune disease","volume":"122","author":"De Ravin","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.amjms.2025.07.012_bib0024","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"deLuca","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjms.2025.07.012_bib0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00277-005-1094-5","article-title":"Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease","volume":"84","author":"Trelinski","year":"2005","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.amjms.2025.07.012_bib0026","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.07.012_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2567.2007.02611.x","article-title":"Glucocorticoids exert opposing effects on macrophage function dependent on their concentration","volume":"122","author":"Lim","year":"2007","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.amjms.2025.07.012_bib0028","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.1996.tb08306.x","article-title":"Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes","volume":"103","author":"Lanza","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.amjms.2025.07.012_bib0029","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.012_bib0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial","volume":"75","author":"Morrow","year":"2018","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.amjms.2025.07.012_bib0031","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cid\/cir896","article-title":"Corticosteroid therapy for liver abscess in chronic granulomatous disease","volume":"54","author":"Leiding","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2025.07.012_bib0032","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/520985","article-title":"Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease","volume":"45","author":"Siddiqui","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:43:46Z","timestamp":1758048226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925011085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002962925011085"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.012","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatologic manifestations in an X-Linked chronic granulomatous disease carrier","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}